Literature DB >> 12605242

Epidemiology of erectile dysfunction.

M Kubin1, G Wagner, A R Fugl-Meyer.   

Abstract

This review of the current epidemiological literature on erectile dysfunction (ED) suggests that approximately 5-20% of men have moderate-to-severe ED. Different definitions of ED, age distributions and concomitant medical conditions, as well as methodological differences, may explain much of the variance in reported prevalence rates. Various chronic disorders are associated with elevated rates of ED including depression, diabetes, and cardiovascular and neurological diseases. Such disorders are more common in the elderly, which may partially explain the elevated prevalence of ED in men over 60 y of age. Currently, up to 70% of men with ED are not treated. However, so many men experience considerable distress from their condition, that the increasing awareness of ED as well as the availability of noninvasive treatments may result in a greater proportion of patients seeking treatment, and eventually regaining satisfaction with their sex life.

Entities:  

Mesh:

Year:  2003        PMID: 12605242     DOI: 10.1038/sj.ijir.3900949

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  40 in total

1.  Are subjects with erectile dysfunction aware of their condition? Results from a retrospective study based on an Italian free-call information service.

Authors:  A Aversa; A M Isidori; D Gianfrilli; E A Greco; A Graziottin; G Zizzo; A Lenzi; A Fabbri
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

2.  Treatment expectations of men with ED and their female partners: an exploratory qualitative study based on grounded theory.

Authors:  S Henninger; C Höhn; C Leiber; M M Berner
Journal:  Int J Impot Res       Date:  2015-06-11       Impact factor: 2.896

3.  Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors.

Authors:  W-K Tsai; B-P Jiann
Journal:  Int J Impot Res       Date:  2014-01-23       Impact factor: 2.896

4.  Hypogonadism in DM1 and its relationship to erectile dysfunction.

Authors:  Giovanni Antonini; Alessandro Clemenzi; Elisabetta Bucci; Emanuela De Marco; Stefania Morino; Antonella Di Pasquale; Pamela Latino; Gilda Ruga; Andrea Lenzi; Nicola Vanacore; Antonio F Radicioni
Journal:  J Neurol       Date:  2011-02-23       Impact factor: 4.849

5.  Prescription opioids for back pain and use of medications for erectile dysfunction.

Authors:  Richard A Deyo; David H M Smith; Eric S Johnson; Carrie J Tillotson; Marilee Donovan; Xiuhai Yang; Amanda Petrik; Benjamin J Morasco; Steven K Dobscha
Journal:  Spine (Phila Pa 1976)       Date:  2013-05-15       Impact factor: 3.468

6.  Sexual dysfunction in male Iraq and Afghanistan war veterans: association with posttraumatic stress disorder and other combat-related mental health disorders: a population-based cohort study.

Authors:  Benjamin N Breyer; Beth E Cohen; Daniel Bertenthal; Raymond C Rosen; Thomas C Neylan; Karen H Seal
Journal:  J Sex Med       Date:  2013-05-16       Impact factor: 3.802

7.  Sexual Health in Male and Female Iraq and Afghanistan U. S. War Veterans With and Without PTSD: Findings From the VALOR Cohort.

Authors:  Benjamin N Breyer; Shona C Fang; Karen H Seal; Gayatri Ranganathan; Brian P Marx; Terence M Keane; Raymond C Rosen
Journal:  J Trauma Stress       Date:  2016-04-29

8.  Erectile dysfunction in COPD patients.

Authors:  Onur Turan; Iyimser Ure; Pakize Ayse Turan
Journal:  Chron Respir Dis       Date:  2015-12-08       Impact factor: 2.444

Review 9.  A review of the efficacy and safety of mirodenafil in the management of erectile dysfunction.

Authors:  Min Chul Cho; Jae-Seung Paick
Journal:  Ther Adv Urol       Date:  2016-01-19

Review 10.  Toward a new 'EPOCH': optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction.

Authors:  R Sadovsky; G B Brock; S W Gutkin; S Sorsaburu
Journal:  Int J Clin Pract       Date:  2009-08       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.